Skip to search formSkip to main contentSkip to account menu

TC 1734

Known as: AZD3480, TC-1734, TC1734 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ispronicline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
2012
2012
Nicotine Receptor Subtype-Specific Effects on Auditory Evoked Oscillations and Potentials
Background Individuals with schizophrenia show increased smoking rates which may be due to a beneficial effect of nicotine on… 
2012
2012
Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats
Nicotinic acetylcholine systems play major roles in cognitive function. Nicotine and a variety of nicotinic agonists improve… 
2011
2011
subjects with age-associated memory impairment mg TC-1734 ( AZD 3480 ) with placebo , in older A randomized double-blind study comparing 25 and 50
Cognitive decline is a feature of ageing and can be defined as normal (age-associated memory impairment) or pathological (mild… 
2010
2010
Evaluation of the Effects of AZD3480 on Cardiac Repolarization: A Thorough QT/QTc Study Using Moxifloxacin as a Positive Control
In order to evaluate their potential effects on cardiac repolarization, all new drugs must undergo clinical electrocardiographic… 
2009
2009
12th International Conference on Alzheimer's Disease (ICAD), Vienna, Austria.
21 July 2009. In like a lamb, out like a lion. It’s a full season too late for this variation on the March weather proverb, but… 
2007
2007
Cognitive enhancement in man with ispronicline, a nicotinic partial agonist
Cholinergic mechanisms are clearly involved in memory deficits associated with Alzheimer's disease (AD) (Perry et al., 1977… 
2006
2006
Pharmacokinetics and Safety Profile of Ispronicline (TC‐1734), a New Brain Nicotinic Receptor Partial Agonist, in Young Healthy Male Volunteers
Recent research suggests that drugs activating nicotine acetylcholine receptors might be promising therapy in cognitive decline… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)